Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-076228
Filing Date
2014-12-17
Accepted
2014-12-17 13:51:33
Documents
1
Period of Report
2014-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3257
  Complete submission text file 0001209191-14-076228.txt   4740
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12750 HIGH BLUFF DRIVE SUITE 310 SAN DIEGO CA 92130
Business Address
Cohen Kenneth M (Reporting) CIK: 0001346981 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31265 | Film No.: 141292079